Novelion Therapeutics Inc. (NVLN) financial statements (2021 and earlier)

Company profile

Business Address C/O NORTON ROSE FULBRIGHT
VANCOUVER, BC V6B 0M3
State of Incorp. BC
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 452740525571
Cash and cash equivalents 452740525571
Restricted cash and investments     01
Receivables27292218162215
Inventory, net of allowances, customer advances and progress billings13131913131616
Inventory13131913131616
Other undisclosed current assets66161515141130
Total current assets:106103838696105131
Noncurrent Assets
Inventory, Noncurrent38363238393440
Property, plant and equipment1222333
Intangible assets, net (including goodwill)194200206213219225232
Intangible assets, net (excluding goodwill)194200206213219225232
Other noncurrent assets3111222
Total noncurrent assets:236239242254263264277
TOTAL ASSETS:342342325340358369408
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities47505756505657
Accounts payable661311141416
Accrued liabilities40444446364241
Debt14774303    
Contract with customer, liability24    
Other undisclosed current liabilities2252871098933
Total current liabilities:44341037165586490
Noncurrent Liabilities
Long-term debt and lease obligation   1615259250
Long-term debt, excluding current maturities   1615259250
Liabilities, other than long-term debt2111211
Other liabilities2111211
Other undisclosed noncurrent liabilities1619233032973130
Total noncurrent liabilities:182023320314290280
Total liabilities:461431394385372354370
Stockholders' equity
Stockholders' equity attributable to parent(119)(89)(69)(45)(13)1538
Common stock553553553553552552552
Additional paid in capital80797978777372
Accumulated other comprehensive income103102102102104104104
Accumulated deficit(854)(822)(803)(778)(747)(714)(689)
Total stockholders' equity:(119)(89)(69)(45)(13)1538
TOTAL LIABILITIES AND EQUITY:342342325340358369408

Income statement (P&L) ($ in millions)

3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
Revenues32413032273929
Revenue, net273929
Cost of revenue
(Cost of Goods and Services Sold)
(15)(18)(13)(16)(14)(17)(30)
Gross profit:172318161422(1)
Operating expenses(33)(22)(30)(34)(35)(36)(39)
Operating income (loss):(16)1(12)(18)(21)(14)(39)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
(1)0(1)(1)(0)(0)0
Interest and debt expense(2)(4)  (0)  
Loss from continuing operations before equity method investments, income taxes:(18)(3)(13)(19)(22)(14)(39)
Other undisclosed loss from continuing operations before income taxes(14)(16)(12)(12)(11)(10)(10)
Loss from continuing operations before income taxes:(32)(19)(25)(30)(33)(25)(49)
Income tax expense (benefit)0(0)(0)(1)(0)0(0)
Net loss available to common stockholders, diluted:(32)(19)(25)(31)(33)(25)(50)

Comprehensive Income ($ in millions)

3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
Net loss:(32)(19)(25)(31)(33)(25)(50)
Comprehensive loss:(32)(19)(25)(31)(33)(25)(50)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1(1)(0)(2)10(0)
Comprehensive loss, net of tax, attributable to parent:(31)(20)(25)(33)(32)(24)(50)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: